Skip to main content
Skip to content
Case File
efta-efta01521333DOJ Data Set 10Correspondence

EFTA Document EFTA01521333

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01521333
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL ACCT. For the Period 8/1/12 to 8/31/12 Equity Summary Asset Categories US Large Cap Equity 54,327.28 54,565.93 238.65 1% US Small/Mkt Cap Equity 5,160.00 8,280.00 3,120.00 1% Non-US Equity 138.50 130.36 (8.15) 1% Preferred Stocks 444,730.00 448,809.00 2,079.00 5% Concentrated 8 Other Equity 198.494.00 202,986.00 4,492.00 2% Total Value 5702,849.78 5712,771.28 $9,921.50 10% Beginning Ending Change Current Asset Categories Market Value Market Value In Value Allocation Market Value/Cost Current Period Value Market Value 712,771.28 Tax Cost 764,967.39 Unrealized Gain/Loss (52,196.11) Estimated Annual Income 45,693.48 Accrued Dividends 4,611.62 Yield 6.39% Equity Detail Nori-US Equity US Small litd Cap Equety US Large Cap Equity Equity as a percentage of your portfolio - 10 % Prolenfl Stocks Concentrated 6 Other Equty Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Dlv. Yield US Large Cap Equity APACHE CORP 037411-10-5 APA 85.75 95.000 8,146.25 11,403.30 (3,257.05) 64.60 0.79% JP Morgan Page 5 of 28 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048710 SDNY_GM_00317908 EFTA01521333

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.